Antibiotics Aren’t Profitable Enough for Big Pharma to Make More
Do You Need a Measles Booster?
Patients' drug costs surge for some neurologic conditions
April 29, 2019
https://www.reuters.com/article/us-health-neurology-drug-costs/patients-drug-costs-surge-for-some-neurologic-conditions-idUSKCN1S74P5
In this April 29, 2019, article from Reuters Health, Stacie Dusetzina, PhD, associate professor in the Department of Health Policy, explains why rising drug prices for neurological conditions like epilepsy and multiple sclerosis can create potentially riskier situations for patients and higher rates of emergency department use for hospitals.
Vanderbilt research hub to examine issues faced by children at risk for poor health, education outcomes
November 15, 2018
By Joan Brasher and Jill Clendening
Experts from Vanderbilt University School of Medicine’s Department of Health Policy and Vanderbilt University’s Peabody College of Education and Human Development are joining efforts to establish a Policies for Action (P4A) Research Hub at Vanderbilt to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including children in immigrant families and children with prenatal exposure to opioids.